These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27055204)

  • 1. Managing diabetes in hospitalized patients with chronic kidney disease.
    Iyer SN; Tanenberg RJ
    Cleve Clin J Med; 2016 Apr; 83(4):301-10. PubMed ID: 27055204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Brøsen JMB; Bomholt T; Borg R; Persson F; Pedersen-Bjergaard U
    Ugeskr Laeger; 2024 May; 186(20):. PubMed ID: 38808757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?
    Haneda M; Morikawa A
    Nephrol Dial Transplant; 2009 Feb; 24(2):338-41. PubMed ID: 19015168
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycated albumin in diabetic patients with chronic kidney disease.
    Zheng CM; Ma WY; Wu CC; Lu KC
    Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing blood glucose levels in patients with diabetes and renal impairment.
    Chowdhury TA; O'Toole S; Yaqoob MM
    Br J Hosp Med (Lond); 2016 Jan; 77(1):C10-3. PubMed ID: 26903465
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.
    Busch M; Nadal J; Schmid M; Paul K; Titze S; Hübner S; Köttgen A; Schultheiss UT; Baid-Agrawal S; Lorenzen J; Schlieper G; Sommerer C; Krane V; Hilge R; Kielstein JT; Kronenberg F; Wanner C; Eckardt KU; Wolf G;
    BMC Nephrol; 2016 Jun; 17(1):59. PubMed ID: 27286816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agents for the treatment of diabetes mellitus.
    O'Mara NB
    Semin Dial; 2010; 23(5):475-9. PubMed ID: 21069919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of type 2 diabetes mellitus in patients with chronic kidney disease. Grupo de Trabajo para el Documento de Consenso sobre el tratamiento de la diabetes tipo 2 en el paciente con enfermedad renal crónica].
    Gómez-Huelgas R; Martínez-Castelao A; Artola S; Górriz JL; Menéndez E;
    Med Clin (Barc); 2014 Jan; 142(2):85.e1-10. PubMed ID: 24268912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, epidemiological study of the treatment patterns, comorbidities and hypoglycemia events of patients with type 2 diabetes and moderate or severe chronic kidney disease - the 'LEARN' study.
    Rombopoulos G; Panitti E; Varounis C; Katsinas C; Stefanidis I; Goumenos D
    Curr Med Res Opin; 2016 May; 32(5):939-47. PubMed ID: 26857244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing your blood glucose ups and downs.
    Griffin S; Ballard D
    Diabetes Self Manag; 2009; 26(1):36, 38, 41-2 passim. PubMed ID: 19213144
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of efficacy and safety of three novel hypoglycemic agents in patients with severe diabetic kidney disease: A systematic review and network meta-analysis of randomized controlled trials.
    Li Y; Hu Y; Huyan X; Chen K; Li B; Gu W; Mu Y
    Front Endocrinol (Lausanne); 2022; 13():1003263. PubMed ID: 36353233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD.
    Galindo RJ; de Boer IH; Neumiller JJ; Tuttle KR
    Clin J Am Soc Nephrol; 2023 Jan; 18(1):130-145. PubMed ID: 36719162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
    Bae JP; Duan R; Fu H; Hoogwerf BJ
    Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Study: using a continuous glucose monitoring system in a patient with diabetes and beta-thalassemia hemoglobinopathy.
    Al-Futaisi A; Wali Y; El-Beshlawi I; Al-Riyami S; Almahrezi A
    Pediatr Hematol Oncol; 2009; 26(7):515-9. PubMed ID: 19863207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A balancing act: achieving glycemic control in hospitalized patients.
    Kubacka B
    Nursing; 2014 Jan; 44(1):30-7; quiz 37-8. PubMed ID: 24285022
    [No Abstract]   [Full Text] [Related]  

  • 17. Some specificities in the management of hyperglycemia in patients with diabetic kidney disease.
    Dragović T; Marinković D; Kiković S; Pejović J; Hajduković Z
    Vojnosanit Pregl; 2016 Sep; 73(9):857-63. PubMed ID: 29320619
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monitoring of the insulin treated diabetic].
    Soltani D; Perlemuter L
    Presse Med; 1998 Jul 4-11; 27(24):1251-4. PubMed ID: 9767789
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
    Galindo RJ; Beck RW; Scioscia MF; Umpierrez GE; Tuttle KR
    Endocr Rev; 2020 Oct; 41(5):756-74. PubMed ID: 32455432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.